Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00980031 · ClinicalTrials.gov registry record · NA
Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension
A NA study, sponsored by Creighton University.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00980031: Clinical Trial NA study, sponsored by Creighton University.
NCT00980031 is a NA study that was terminated before completion, run by Creighton University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00980031, a NA study, was terminated before completion, sponsored by Creighton University.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this project is to investigate the effects that the addition of aldosterone blockade with eplerenone will have on the progression of diastolic dysfunction in patients with controlled essential hypertension.
Interventions
- DRUG Eplerenone
- DRUG Lactose Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-04 |
| Est. Completion | 2011-09 |
| Phase | NA |
Why NCT00980031 stopped before completion
NCT00980031 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Eplerenone is the first listed.
NCT00980031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00980031 about?
NCT00980031 is a clinical study titled "Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension". The goal of this project is to investigate the effects that the addition of aldosterone blockade with eplerenone will have on the progression of diastolic dysfunction in patients with controlled essential hypertension.
What is the current status of trial NCT00980031?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2007-04. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00980031?
The interventions under investigation include: Eplerenone (DRUG), Lactose Tablet (DRUG).
Who is sponsoring clinical trial NCT00980031?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00980031's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia